A Stanford study's 12-month follow-up reveals significant improvements in PTSD, depression, and anxiety in Special Operations veterans with TBIs after ibogaine treatment.
A Stanford study's 12-month follow-up reveals significant improvements in PTSD, depression, and anxiety in Special Operations veterans with TBIs after ibogaine treatment.